InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Glickman Mark A. Officer active across 4 companies, notably Aralez Pharmaceuticals Inc.. In total, 5 reports have been logged. History available since 6 December 2022. The latest transaction was disclosed on 30 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Glickman Mark A is a declarant with 5 filings in total. In the 5 sampled recent filings, the transactions are attributions, with a date range from 2016-02-09 to 2025-07-01 and buy and sell amounts of EUR 0 each. The companies mentioned in these filings are MetaVia Inc., NeuroBo Pharmaceuticals, Inc., TherapeuticsMD, Inc. and Aralez Pharmaceuticals Inc., with the listed roles of Director, Co-Chief Executive Officer and Chief Commercial Officer.